$32.38
0.652.05%
Last update: Nov 10, 4:00 PM
Immunocore Holdings PLC
IMCRNASDAQ
Immunocore fell 9.3% from $35.00 to $31.73, behind the S&P 500's +10.0%. Its worst day was Apr 21 (−6.2%), and its low came Jun 8 at $27.79.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Immunocore closed at its highest level of the year, 14.9% above where the year started.
+6.2% · S&P 500 +0.1%
Immunocore shares rose 5.9%, while the S&P 500 rose 1.2%.
+5.9% · S&P 500 +1.2%
Story events cover the past 12 months · Times ET
EPS of $-0.60 missed the $-0.23 estimate on $104.5M revenue (est. $107.8M).
−4.5% · S&P 500 +0.8%
Immunocore shares fell 6.2%, while the S&P 500 fell 0.7%.
−6.2%, the year's worst day · S&P 500 −0.7%
EPS of $0.25 beat the $-0.26 estimate on $106.7M revenue (est. $107.4M).
+6.6% · S&P 500 +1.4%
Immunocore closed at its lowest level of the year, 20.6% below where the year started.
−1.8% · S&P 500 +0.2%
EPS of $-0.02 missed the $0.02 estimate on $115.9M revenue (est. $111.0M).
+3.6% · S&P 500 −0.2%
Immunocore shares rose 9.2%, while the S&P 500 rose 0.3%.
+9.2%, the year's best day · S&P 500 +0.3%
EPS of $-0.28 missed the $-0.13 estimate on $102.2M revenue (est. $113.3M).
+9.1% · S&P 500 +0.3%
Where it ended: a close of $31.73 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $-0.20, revenue est. $114.7M).
Nothing in the past 12 months.
All IMCR dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for IMCR and SPY from Benzinga historical bars. Not investment advice.
